Predicting Length-of-Stay & Risk of Mortality for ICU Patients

Pangaea Data Awarded Top Tier Co-Sell Partnership Status by Microsoft

Pangaea Named ‘Digital Solution of the Year’ by UK Government’s Department for International Trade

Global Pharmaceutical Proves Pangaea’s AI

Go back

Pangaea Presents at Pharmacovigilance World 2021

12:55 PM GMT on Tuesday 23rd November, 2021 during the Drug Safety Strategies & Regulatory track

Our Head of AI, Mr. Jingqing Zhang, and Founder and Director, Dr. Vibhor Gupta, presented at Pharmacovigilance World 2021 on the Novel AI for Extraction of Adverse Events and Auto Generation of Adverse Event Reports.

During this presentation, they shared success stories whereby pharmaceutical companies are applying Pangaea’s novel unsupervised-natural language processing (NLP) combined with their AutoML based product to extract adverse events, clinical features, demographic information, toxicities, drug names to predict causality, discontinuation, interruption and mortality with more than 87.5% accuracy (compared to supervised and information retrieval based approaches) at scale. Additionally, they also presented Pangaea’s (first of its kind) Natural Language Generation (NLG) methods to automatically generate adverse event reports, which has saved 90% of the time currently spent in doing so manually. 

The Pharmacovigilance World 2021 conference provides a platform for the participants to discuss, share and stay updated with present state of affairs in Pharmacovigilance and Drug safety, and how it contributes to the public health. It also allows for all its participants to interact with the experts, discuss the various developments, challenges faced and innovations in the field. Our Pharmacovigilance conferences are known for bringing the world-class leaders together to connect, learn and network.

See the full agenda here

For more information, please contact us at

Contact Us Here


Dr. Vibhor Gupta
Director & Founder
Pangaea Data
Mr. Jingqing Zhang
Head of AI
Pangaea Data